An Ultra-Thin Silicon Nitride Membrane for Label-Free CTCs Isolation from Whole Blood with Low WBC Residue

Yunlin Quan,Zhixian Zhu,Dezhi Tang,Shu Zhu,Cailian Wang,Ke Chen,Zhonghua Ni
DOI: https://doi.org/10.1016/j.seppur.2022.121349
IF: 8.6
2022-01-01
Separation and Purification Technology
Abstract:Microfiltration is the most straightforward and effective method to enrich circulating tumor cells (CTCs) from large numbers of background blood cells in the peripheral blood. It is still very challenging to achieve both high recovery of CTCs and low residue of white blood cells (WBCs) through one-time whole blood filtration. In this study, through a simulation, we revealed that reducing the thickness of the filter significantly reduces the WBC residue. A filter device was created using a 400-nm-thick Si3N4 membrane. The recovery rates of A549 and MCF-7 tumor cell lines were 82.04 +/- 1.19% and 86.53 +/- 3.27%, respectively, while the residual number of WBCs was largely reduced from 6.84 x 10(6) cells/mL cells to 604 +/- 33.74 cells/mL. In addition, the assembled device could process whole blood without pretreatment at a high throughput of 1 mL/min. Utilizing as small volume of peripheral blood as 1 mL, CTCs were enriched by our device in four of six lung cancer patients and four of five breast cancer patients. The lower WBC residue is advantageous in CTC enumeration and subsequent proteomic or genomic characterization. Therefore, this technology enables label-free CTC isolation with a low WBC residue from whole blood, paving the way for a CTC analysis in clinical applications.
What problem does this paper attempt to address?